Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer

BACKGROUND: Small cell lung cancer (SCLC) is an aggressive malignancy characterized by initial chemosensitivity followed by resistance and rapid progression. Presently, there are no predictive biomarkers that can accurately guide the use of systemic therapy in SCLC patients. This study explores the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Prantesh, Khorrami, Mohammadhadi, Gupta, Amit, Rajiah, Prabhakar, Bera, Kaustav, Viswanathan, Vidya Sankar, Fu, Pingfu, Dowlati, Afshin, Madabhushi, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564480/
https://www.ncbi.nlm.nih.gov/pubmed/34745966
http://dx.doi.org/10.3389/fonc.2021.744724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564480/
https://www.ncbi.nlm.nih.gov/pubmed/34745966
http://dx.doi.org/10.3389/fonc.2021.744724

Ejemplares similares